Brief: Mauna Kea Technologies Announces Positive Results In Lung Transplant Patients
June 20 (Reuters) - MAUNA KEA TECHNOLOGIES SAS MKEA.PA :
* MAUNA KEA TECHNOLOGIES ANNOUNCES POSITIVE RESULTS FROM
MAYO
CLINIC SPONSORED PROSPECTIVE MULTI-CENTER TRIAL IN LUNG
TRANSPLANT PATIENTS
* CELLVIZIO'S OPTICAL BIOPSY COULD BECOME A SAFE AND
EFFECTIVE
ALTERNATIVE TO INVASIVE BIOPSIES IN TRANSPLANTED PATIENTS
Source text for Eikon: ID:nBw4GSgvKa
Further company coverage: MKEA.PA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Mauna Kea Technologies SA
See all newsBrief: Mauna Kea Technologies Confirms Trajectory Toward Profitability By Year-End 2027
Brief: Mauna Kea Technologies Announces Results Of Its Combined General Meeting
French and Benelux stocks-Factors to watch 21 Nov
Brief: Mauna Kea Technologies Receives NMPA Regulatory Approval In China For Its Next-Generation Cellvizio Platform
Europe Research Roundup: Craneware, Croda, Genus